NCT02544750 2022-07-14An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)Jazz PharmaceuticalsPhase 3 Completed199 enrolled 14 charts
NCT05016349 2021-08-23Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.Kafrelsheikh UniversityPhase 3 Unknown160 enrolled